"
Utilization of Extracorporeal Membrane Oxygenation for Pulmonary Toxicity Caused by Inhaled Synthetic Cannabinoid. A Harbinger of Future Complications Associated with Inhaled Cannabinoid Products"
written by Robert March, Paul Guentert, Elizabeth Kloska-Kearney, David Kwak, Cody Yerger, Michael McBride, J. R. Majewski, Ross McCauley, Jordan Hatch, Jacob Speybroeck, Allen Betts, Mat Marsee, Sufyan Zackariya, Faisal Shariff, Shivani Patel, Ali Sualeh, Anthony Thomas, Edward Evans, Donald Westerhausen, Mark Walsh,
published by
International Journal of Clinical Medicine,
Vol.11 No.2, 2020
has been cited by the following article(s):
|
[1]
|
New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions
Journal of Chemistry,
2023
DOI:10.1155/2023/5852315
|
|
|
|
|
[2]
|
New psychoactive substances: a review and updates
Therapeutic Advances in Psychopharmacology,
2020
DOI:10.1177/2045125320967197
|
|
|
|